Mystic Ventures

Xylo Bio is a drug development company focused on next-generation psychedelic-inspired therapeutics for psychiatric and neurological disorders. Through a psychedelic therapeutic platform, it aims to develop non-hallucinogenic, rapid-acting medicines that can be widely available and provide improvements over current SSRI treatments. The company seeks to rewire neural circuits and restore brain function, enabling clinicians to optimize care and expand treatment options beyond traditional antidepressants.

Spiritus Bioscience is a biotechnology company focused on developing novel psychedelic therapeutics. It specializes in proprietary drug-delivery technologies aimed at enhancing patient experience and safety in mental health treatments, with a current focus on Medicalized-Psilocybin in Oregon.

Awakn Life Sciences is a clinical-stage biotechnology company dedicated to developing and delivering innovative psychedelic medicine aimed at treating addiction, with a primary focus on Alcohol Use Disorder (AUD). The company comprises a multidisciplinary team of chemists, scientists, psychiatrists, and psychologists who are working to create the next generation of psychedelic drugs and therapies, as well as the technologies that enable their use. Recognizing the inadequacies of current treatment options for AUD, Awakn aims to provide breakthrough therapeutics for individuals suffering from addiction, addressing a significant medical need both in the United States and internationally.

Founded in 2022, 2A Biosciences is a pharmaceutical company based in California, USA. It specializes in developing drugs using small molecules that target inflammation through the use of 2A agonists.

Developer of a neuropsychiatric biomarker platform aimed at advancing precision medicine and therapeutic development. The platform integrates AI-driven analytics, computational neuroscience, transdiagnostic efficacy assessments, and digital twin modeling to accelerate clinical trials, improve treatment outcomes, and enhance understanding of brain health across diverse neurological and psychiatric conditions.

Heading Health is a technology-driven platform enhancing access to affordable mental health care. It offers personalized treatment solutions, combining evidence-based therapeutics with advanced technologies like transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine.

DopaGE is an education technology company focused on overdose prevention and response, specifically targeting academic institutions. Its platform provides a cloud-based, gamified curriculum designed to teach students how to prevent, recognize, and respond to drug overdoses, a leading cause of death among GenZ and Millennials. Developed by experts in emergency medicine and neuroscience, DopaGE's engaging content aims to empower students with the knowledge and confidence needed to address overdose situations effectively. By making this vital education accessible and easily implementable, DopaGE seeks to significantly reduce overdose incidents on college campuses and contribute to overall public health.

Journey Clinical offers an online platform that supports independent psychotherapists in expanding their practices to include ketamine-assisted psychotherapy. The company facilitates prescription services, enabling mental health professionals to provide safe and effective psychedelic therapy to patients.

CB Therapeutics is a biotechnology company that develops biosynthetic production of cannabinoids from sugar, using yeast to produce cannabinoids such as CBD and THC without plant material. The company aims to enable next-generation production of cannabinoids and related psychedelic medicines and analogs through a cellular agriculture platform, supporting clinical research and exploration of treatments for mental health conditions and other diseases.

Nucleus is a venture studio focused on supporting emerging companies in the psychedelic ecosystem. It provides a range of services that facilitate connections within the psychedelics industry, including therapy, education, and access to a community of investors. By incubating these companies, Nucleus aims to advance alternative medicines and promote mental health solutions, helping them establish strong brands and contribute to the growing community dedicated to the responsible use of psychedelic therapies.

Enthea facilitates access to safe and affordable psychedelic-assisted therapies as an employee benefit. It connects businesses with certified practitioners for Ketamine-Assisted Therapy and Psychedelic-Assisted Therapy, offering workplace plans that cover these critical mental health treatments.

Spiritus Bioscience is a biotechnology company focused on developing novel psychedelic therapeutics. It specializes in proprietary drug-delivery technologies aimed at enhancing patient experience and safety in mental health treatments, with a current focus on Medicalized-Psilocybin in Oregon.

Psilera is a biopharmaceutical company dedicated to developing innovative therapeutics for neurodegenerative diseases through the use of psychedelic compounds. The company focuses on creating a new class of neurological medicines, with its lead asset, PSIL-006, being a non-hallucinogenic derivative of psilocybin aimed at treating frontotemporal dementia. Psilera’s approach involves repurposing psychoactive natural products as foundational elements for next-generation therapies that enhance mental health. By prioritizing scientific excellence, Psilera seeks to transform the lives of individuals affected by cognitive, mood, and substance use disorders, marking a significant advancement in the field of mindful medicine.

Beckley Retreats is a provider of virtual integration programs designed to support individuals with neurological and psychiatric disorders. The company specializes in facilitating safe and legal psychedelic retreats that offer scientific insights into healing practices. Beckley Retreats emphasizes holistic training and dedicated care, ensuring that participants have access to necessary medical support. Additionally, the company provides training and certification programs for practitioners, equipping them with the skills needed to guide others through their healing journeys.

Naitur.ai is a company focused on enhancing psychedelic healthcare through a specialized practice management platform. Founded in 2019 and based in Denver, Colorado, the platform allows practitioners to track, manage, and measure health outcomes effectively. It offers personalized protocols and psychedelic-specific assessments that help in monitoring dosages, wellness outcomes, and psychological metrics. By streamlining these processes, Naitur.ai aims to reduce the workload for psychedelic practitioners, enabling them to serve a larger number of clients and improve mental health and well-being in the communities they support.

CB Therapeutics is a biotechnology company that develops biosynthetic production of cannabinoids from sugar, using yeast to produce cannabinoids such as CBD and THC without plant material. The company aims to enable next-generation production of cannabinoids and related psychedelic medicines and analogs through a cellular agriculture platform, supporting clinical research and exploration of treatments for mental health conditions and other diseases.

Sempera Organics is a vertically integrated lab farm dedicated to producing high-quality, certified organic mushroom ingredients and products. The company focuses on sustainability with a zero-waste approach, offering a variety of mushroom options designed for both wet and dry applications. Sempera Organics specializes in pure mushroom powders, proprietary blends, and extracts, all available in bulk quantities. Its products cater to the functional foods, nutraceuticals, and cosmeceuticals industries, providing clinically relevant mushroom ingredients. By prioritizing environmentally friendly cultivation methods and a streamlined purchasing process, Sempera Organics aims to deliver reliable and effective solutions to its consumers.

Freedom Biosciences develops a biotechnology platform focused on next-generation psychedelic therapeutics. The company advances ketamine-based therapies and combines neuropsychiatric drugs to create treatments for mental health and substance use disorders, including depression and PTSD, with the aim of offering more effective and safer options for patients.

Journey Clinical offers an online platform that supports independent psychotherapists in expanding their practices to include ketamine-assisted psychotherapy. The company facilitates prescription services, enabling mental health professionals to provide safe and effective psychedelic therapy to patients.

Heading Health is a technology-driven platform enhancing access to affordable mental health care. It offers personalized treatment solutions, combining evidence-based therapeutics with advanced technologies like transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine.

Stillmind is a precision neuroscience company focused on targeted small molecule discovery for treating brain disorders. It employs AI-enabled technology and biology-first principles to develop medicines tailored to molecular patient subtypes, initially targeting bipolar disorder.

Multiverse is a digital marketplace that focuses on functional mushrooms, providing a variety of products including superfoods, snacks, supplements, and accessories. The company aims to popularize functional mushrooms and foster collaboration within the psychedelics industry. Multiverse positions itself as the world's first dedicated platform for functional mushrooms, promoting not only their health benefits but also integrating a culture around them through unique offerings such as health supplements and streetwear items. This approach reflects a commitment to making these products appealing and accessible to a broader audience.

Heading Health is a technology-driven platform enhancing access to affordable mental health care. It offers personalized treatment solutions, combining evidence-based therapeutics with advanced technologies like transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine.

Adamo Bioscience is a pharmaceutical company focused on developing innovative treatments for Hypoactive Sexual Desire Disorder (HSDD). The company is engaged in researching psychedelic compounds and technology solutions aimed at enhancing interpersonal connections and promoting emotional healing. Adamo Bioscience offers a range of products and services designed to foster love and strengthen relationships, as well as to address and heal sexual trauma. Through its unique approach, the company seeks to empower individuals to improve their relationships and overall emotional well-being.

Psychedelic Water is a pioneering brand offering kava-based beverages infused with damiana leaf and green tea extract. Their products aim to provide consumers with a legal, mild psychedelic experience, promoting relaxation, mood elevation, and creative stimulation.

MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. The organization is focused on developing psychedelics and marijuana into prescription medicines, training therapists and working to establish a network of treatment centers, supporting scientific research into spirituality, creativity, and neuroscience, and educating the public honestly about the risks and benefits of psychedelics and marijuana. MAPS was founded in 1986 by Rick Doblin and is headquartered in Santa Cruz, California.

Driving Innovation at the Intersection of VR, Data, and Mental Health

Breathwrk develops a mobile application offering science-backed guided breathing exercises. Users can manage mental wellness by reducing anxiety, improving sleep, enhancing focus, and boosting energy.

Lykos Therapeutics aims to transform mental health treatment by developing innovative medicines and therapies assisted by psychedelics. With over three decades of experience, they focus on rigorous scientific research to create novel therapeutic options.

FireflyVR specializes in developing innovative Virtual Reality (VR) experiences aimed at positively impacting physical health, mental well-being, education, and research. Their flagship product, The Sanctuary, is a clinically designed VR solution that prepares patients for transformative ketamine treatments by incorporating cognitive behavioral therapy techniques to reduce anxiety and enhance therapeutic outcomes.

Wake Network, Inc. is a Toronto-based company that specializes in clinical research and the development of wellness solutions through fungi and plant-based medicine. Founded in June 2018, it combines expertise from wellness professionals and advanced technology to create innovative healing benefits for the mind and body. The company has established a regenerative feedback loop, enabling it to conduct research, monitor outcomes, and integrate findings from clinical studies on a personalized basis. This approach positions Wake Network at the forefront of advancements in mental and holistic health.

HOLOS is a boutique wellness center that specializes in immersive body and mind programming, emphasizing plant medicine experiences. The center focuses on consciousness expansion and healthy living, offering retreats designed to facilitate transformation and healing. Drawing on modern neuroscience and indigenous wisdom, HOLOS provides an environment that supports guests in their personal growth journeys. Through its unique approach, the company aims to establish a new standard in wellness, integrating various practices to enhance overall well-being.

Psychedelic Water is a pioneering brand offering kava-based beverages infused with damiana leaf and green tea extract. Their products aim to provide consumers with a legal, mild psychedelic experience, promoting relaxation, mood elevation, and creative stimulation.